Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Existing and emerging therapies for irritable bowel syndrome.

Acosta RD, Cash BD.

Expert Opin Emerg Drugs. 2011 Jun;16(2):389-402. doi: 10.1517/14728214.2011.566214. Epub 2011 Mar 26. Review.

PMID:
21438740
2.

A review of irritable bowel syndrome and an update on therapeutic approaches.

Bassett JT, Cash BD.

Expert Opin Pharmacother. 2008 May;9(7):1129-43. doi: 10.1517/14656566.9.7.1129. Review.

PMID:
18422471
3.
4.

The spectrum of irritable bowel syndrome: A clinical review.

Gilkin RJ Jr.

Clin Ther. 2005 Nov;27(11):1696-709. Review.

PMID:
16368443
5.

Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome.

Nee J, Zakari M, Lembo AJ.

Expert Opin Pharmacother. 2015;16(18):2781-92. doi: 10.1517/14656566.2015.1101449. Epub 2015 Nov 11. Review.

PMID:
26558923
6.

Tegaserod for the treatment of irritable bowel syndrome.

Evans BW, Clark WK, Moore DJ, Whorwell PJ.

Cochrane Database Syst Rev. 2004;(1):CD003960. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD003960.

PMID:
14974049
7.

Meta-analysis: The treatment of irritable bowel syndrome.

Lesbros-Pantoflickova D, Michetti P, Fried M, Beglinger C, Blum AL.

Aliment Pharmacol Ther. 2004 Dec;20(11-12):1253-69.

8.

Investigational agents for the irritable bowel syndrome.

Ghaith O, El-Halabi M, Hashash JG, Sharara AI.

Expert Opin Investig Drugs. 2010 Oct;19(10):1161-78. doi: 10.1517/13543784.2010.513380. Review.

PMID:
20836617
9.

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.

Evans BW, Clark WK, Moore DJ, Whorwell PJ.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003960. Review.

PMID:
17943807
10.

Current medical treatments of dyspepsia and irritable bowel syndrome.

Camilleri M, Tack JF.

Gastroenterol Clin North Am. 2010 Sep;39(3):481-93. doi: 10.1016/j.gtc.2010.08.005. Review.

PMID:
20951913
11.

The brain-gut axis in irritable bowel syndrome--clinical aspects.

Mach T.

Med Sci Monit. 2004 Jun;10(6):RA125-31. Epub 2004 Jun 1. Review.

PMID:
15173682
12.

Drugs for irritable bowel syndrome.

[No authors listed]

Treat Guidel Med Lett. 2011 Jul;9(107):41-6. No abstract available.

PMID:
21701443
13.

Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation.

Ponziani FR, Pecere S, Lopetuso L, Scaldaferri F, Cammarota G, Gasbarrini A.

Expert Opin Drug Saf. 2016 Jul;15(7):983-91. doi: 10.1080/14740338.2016.1186639. Epub 2016 May 23. Review.

PMID:
27149541
14.

Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment.

Chang JY, Talley NJ.

Trends Pharmacol Sci. 2010 Jul;31(7):326-34. doi: 10.1016/j.tips.2010.04.008. Epub 2010 Jun 1. Review.

PMID:
20554042
15.

Emerging drugs for irritable bowel syndrome.

Bradesi S, Tillisch K, Mayer E.

Expert Opin Emerg Drugs. 2006 May;11(2):293-313. Review.

PMID:
16634703
16.

Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome.

Camilleri M.

Expert Opin Pharmacother. 2013 Jun;14(9):1151-60. doi: 10.1517/14656566.2013.794223. Epub 2013 Apr 27. Review.

PMID:
23621801
17.

Current and novel therapeutic options for irritable bowel syndrome management.

Camilleri M, Andresen V.

Dig Liver Dis. 2009 Dec;41(12):854-62. doi: 10.1016/j.dld.2009.07.009. Epub 2009 Aug 8. Review.

18.

Treatment options in irritable bowel syndrome.

Farthing MJ.

Best Pract Res Clin Gastroenterol. 2004 Aug;18(4):773-86. Review.

PMID:
15324713
19.

Irritable bowel syndrome: recent and novel therapeutic approaches.

Andresen V, Camilleri M.

Drugs. 2006;66(8):1073-88. Review.

PMID:
16789793
20.

Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners.

Grundmann O, Yoon SL.

J Gastroenterol Hepatol. 2010 Apr;25(4):691-9. doi: 10.1111/j.1440-1746.2009.06120.x. Epub 2010 Jan 13. Review.

PMID:
20074154

Supplemental Content

Support Center